At present, diabetes caused a significant down-regulation of Nrf2 and downstream molecules such as NQO-1 and Prdx-1, and CVB-D alleviated the expression of these proteins both in vivo and in vitro. This evidence concerns the gene NFE2L2 and diabetes mellitus.